» Articles » PMID: 15850036

Comparison of Papanicolaou (Pap) Test Rates Across Ontario and Factors Associated with Cervical Screening

Overview
Publisher Springer Nature
Specialty Public Health
Date 2005 Apr 27
PMID 15850036
Citations 8
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Cervical cancer remains a significant yet preventable disease despite the widespread availability of Pap test screening, which detects cervical cancer and its precursor lesions. The aims of this study were to: i) estimate and compare age- and hysterectomy-adjusted Pap test rates across the 37 Ontario public health units (PHUs), and ii) explore the association between several factors and Pap test rates (at the ecological level).

Methods: Cytobase, an Ontario Pap test registry, captures more than 80% of all Pap tests in Ontario. Cytobase was used to determine Pap test rates adjusted for age, hysterectomy and Cytobase coverage for the year 2001. Multiple linear regression analyses were used to evaluate the relationship between Pap test rates and various factors at an ecological level,

Results: Age-, hysterectomy- and Cytobase-adjusted one-year Pap rates ranged from 11.6% to 73.9% among PHUs. The overall rate for Ontario was 40.7%. Multivariate analyses indicated that the presence of a teaching hospital was associated with higher Pap test rates.

Conclusion: One-year Pap test rates varied greatly across the 37 public health units in Ontario. Pap test rates determined using Cytobase were lower than self-reported rates obtained from the Canadian Community Health Survey, possibly due to "over-reporting". In general, women were not screened as frequently as recommended by the Ontario Cervical Screening Program. A positive association was observed between Pap test rates and the presence of a teaching hospital. Data quality issues limit the ability to monitor cervical screening. A provincial registry would address these issues.

Citing Articles

No evidence of excessive cancer screening in female noncarriers from mutation-positive families.

Guedaoura S, Pelletier S, Foulkes W, Hamet P, Simard J, Wong N Curr Oncol. 2017; 24(6):352-359.

PMID: 29270046 PMC: 5736476. DOI: 10.3747/co.24.3759.


The validity of self-reported cancer screening history and the role of social disadvantage in Ontario, Canada.

Lofters A, Vahabi M, Glazier R BMC Public Health. 2015; 15:28.

PMID: 25630218 PMC: 4319224. DOI: 10.1186/s12889-015-1441-y.


Strategies for Increasing Cervical Cancer Screening Amongst First Nations Communities in Northwest Ontario, Canada.

Maar M, Wakewich P, Wood B, Severini A, Little J, Burchell A Health Care Women Int. 2014; 37(4):478-95.

PMID: 25375661 PMC: 4798779. DOI: 10.1080/07399332.2014.959168.


Self-collected HPV testing improves participation in cervical cancer screening: a systematic review and meta-analysis.

Racey C, Withrow D, Gesink D Can J Public Health. 2013; 104(2):e159-66.

PMID: 23618210 PMC: 6973997.


Sociodemographic factors associated with cervical cancer screening and follow-up of abnormal results.

Elit L, Krzyzanowska M, Saskin R, Barbera L, Razzaq A, Lofters A Can Fam Physician. 2012; 58(1):e22-31.

PMID: 22267636 PMC: 3264035.


References
1.
Sasieni P, Cuzick J . Estimating the efficacy of screening by auditing smear histories of women with and without cervical cancer. The National Co-ordinating Network for Cervical Screening Working Group. Br J Cancer. 1996; 73(8):1001-5. PMC: 2075813. DOI: 10.1038/bjc.1996.196. View

2.
Pizarro J, Schneider T, Salovey P . A source of error in self-reports of pap test utilization. J Community Health. 2002; 27(5):351-6. DOI: 10.1023/a:1019888627113. View

3.
Finkelstein M . Preventive screening. What factors influence testing?. Can Fam Physician. 2002; 48:1494-501. PMC: 2214098. View

4.
Goel V . Factors associated with cervical cancer screening: results from the Ontario Health Survey. Can J Public Health. 1994; 85(2):125-7. View

5.
Carriere K, Roos L . Comparing standardized rates of events. Am J Epidemiol. 1994; 140(5):472-82. DOI: 10.1093/oxfordjournals.aje.a117269. View